Table 2. In Vitro Permeability (Pe) Values with Related Predictive Penetrations into the CNS of Commercial Drugs, 5 and 6.
BBB penetration estimation | ||
---|---|---|
compound | Pe ± SEM (× 10–6 cm/s)a | CNS (+/−) |
5 | 6.99 ± 1.04 | CNS + |
6 | 17.70 ± 4.63 | CNS + |
furosemide | 0.19 ± 0.07 | CNS – |
ranitidine | 0.35 ± 0.31 | CNS – |
donepezil | 21.93 ± 2.06 | CNS – |
tacrine (4a) | 5.96 ± 0.59 | CNS – |
Pe ± SEM (n = 3). Each compound was assessed in quadruplicate.